Genelux Corp (GNLX)
2.69
+0.04
(+1.51%)
USD |
NASDAQ |
May 31, 16:00
2.70
+0.01
(+0.37%)
After-Hours: 20:00
Genelux Price to Book Value: 4.814 for May 31, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 4.814 |
| May 30, 2024 | 4.743 |
| May 29, 2024 | 5.011 |
| May 28, 2024 | 4.993 |
| May 24, 2024 | 4.689 |
| May 23, 2024 | 8.233 |
| May 22, 2024 | 8.698 |
| May 21, 2024 | 8.985 |
| May 20, 2024 | 7.696 |
| May 17, 2024 | 6.533 |
| May 16, 2024 | 6.443 |
| May 15, 2024 | 6.515 |
| May 14, 2024 | 6.407 |
| May 13, 2024 | 6.461 |
| May 10, 2024 | 6.855 |
| May 09, 2024 | 7.195 |
| May 08, 2024 | 6.783 |
| May 07, 2024 | 6.533 |
| May 06, 2024 | 6.873 |
| May 03, 2024 | 6.855 |
| May 02, 2024 | 6.228 |
| May 01, 2024 | 5.870 |
| April 30, 2024 | 5.566 |
| April 29, 2024 | 5.674 |
| April 26, 2024 | 6.085 |
| Date | Value |
|---|---|
| April 25, 2024 | 5.942 |
| April 24, 2024 | 6.175 |
| April 23, 2024 | 6.228 |
| April 22, 2024 | 5.996 |
| April 19, 2024 | 7.392 |
| April 18, 2024 | 6.908 |
| April 17, 2024 | 6.47 |
| April 16, 2024 | 6.300 |
| April 15, 2024 | 6.801 |
| April 12, 2024 | 7.374 |
| April 11, 2024 | 7.660 |
| April 10, 2024 | 7.785 |
| April 09, 2024 | 8.233 |
| April 08, 2024 | 8.358 |
| April 05, 2024 | 8.824 |
| April 04, 2024 | 8.466 |
| April 03, 2024 | 8.698 |
| April 02, 2024 | 9.396 |
| April 01, 2024 | 9.378 |
| March 31, 2024 | |
| March 28, 2024 | 8.871 |
| March 27, 2024 | 8.305 |
| March 26, 2024 | 8.209 |
| March 25, 2024 | 8.447 |
| March 22, 2024 | 8.557 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.689
Minimum
May 24 2024
361.01
Maximum
Jun 21 2023
68.31
Average
19.32
Median
Price to Book Value Benchmarks
| Verastem Inc | 4.012 |
| CEL-SCI Corp | 4.581 |
| AIM ImmunoTech Inc | 4.487 |
| IGC Pharma Inc | 3.428 |
| NovaBay Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| Price | 2.69 |
| Earnings Yield | -36.06% |
| Market Cap | 72.62M |